These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8353870)

  • 1. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
    Powell AC; Fuchs T; Finkelstein DM; Garan H; Cannom DS; McGovern BA; Kelly E; Vlahakes GJ; Torchiana DF; Ruskin JN
    Circulation; 1993 Sep; 88(3):1083-92. PubMed ID: 8353870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
    Wever EF; Hauer RN; van Capelle FL; Tijssen JG; Crijns HJ; Algra A; Wiesfeld AC; Bakker PF; Robles de Medina EO
    Circulation; 1995 Apr; 91(8):2195-203. PubMed ID: 7697849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias.
    Crandall BG; Morris CD; Cutler JE; Kudenchuk PJ; Peterson JL; Liem LB; Broudy DR; Greene HL; Halperin BD; McAnulty JH
    J Am Coll Cardiol; 1993 Apr; 21(5):1186-92. PubMed ID: 8459075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest.
    Birnie DH; Sambell C; Johansen H; Williams K; Lemery R; Green MS; Gollob MH; Lee DS; Tang AS
    CMAJ; 2007 Jul; 177(1):41-6. PubMed ID: 17606938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
    Siebels J; Kuck KH
    Am Heart J; 1994 Apr; 127(4 Pt 2):1139-44. PubMed ID: 8160593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of left ventricular function on outcome of patients treated with implantable defibrillators.
    Kim SG; Fisher JD; Choue CW; Gross J; Roth J; Ferrick KJ; Brodman R; Furman S
    Circulation; 1992 Apr; 85(4):1304-10. PubMed ID: 1555274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy.
    Hennersdorf MG; Niebch V; Vester EG; Winter J; Perings C; Strauer BE
    Cardiology; 2003; 99(4):190-7. PubMed ID: 12845245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patients with an implantable defibrillator live longer?
    Böcker D; Block M; Isbruch F; Wietholt D; Hammel D; Borggrefe M; Breithardt G
    J Am Coll Cardiol; 1993 Jun; 21(7):1638-44. PubMed ID: 8496531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
    Silka MJ; Kron J; Dunnigan A; Dick M
    Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
    Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical coronary revascularization and antiarrhythmic therapy in survivors of out-of-hospital cardiac arrest.
    Mangi AA; Boeve TJ; Vlahakes GJ; Akins CW; Hilgenberg AD; Ruskin JN; McGovern BM; Torchiana DF
    Ann Thorac Surg; 2002 Nov; 74(5):1510-6. PubMed ID: 12440601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy.
    Almehmadi F; Joncas SX; Nevis I; Zahrani M; Bokhari M; Stirrat J; Fine NM; Yee R; White JA
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):593-600. PubMed ID: 24902587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.